NASDAQ$BTTC

Black Titan Corp · Q1 2019 earnings

Q1 2019 earnings · Reported May 15, 2019 (7 years ago) · Investor relations

May 15Mar 31, 2019

Total Revenue

$56.7K

Previous: $634K-91.1%

EPS (adj)

-$204.00

Previous: -$432.00+52.8%

Capital Expenditures

$44K

Previous: $58K-24.1%

Free Cash Flow

-$4.35M

Previous: -$1.06M-311.7%

Net Income

-$388K

Previous: $90.3K-529.1%

Operating Income

-$369K

Previous: $104K-456.1%

Gross Profit

$31K

Previous: $441K-93.0%

Cash & Equivalents

$97.4K

Previous: $57.9K+68.2%

Total Assets

$3M

Previous: $4.03M-25.5%

Stock-Based Comp

$136K

Previous: $432K-68.5%

Titan Pharmaceuticals · Revenue · Quarterly

$56.7K

Q1 2019-91.1%vs Q1 2018

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation